{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:35:42Z","timestamp":1770356142306,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41390-021-01778-y","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T08:45:55Z","timestamp":1635237955000},"page":"1720-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationships between retinopathy of prematurity without ophthalmologic intervention and neurodevelopment and vision at 2 years"],"prefix":"10.1038","volume":"94","author":[{"given":"Jane E.","family":"Brumbaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn C.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma G.","family":"Crenshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara B.","family":"DeMauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira S.","family":"Adams-Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean R.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girija","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra H.","family":"Wyckoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty R.","family":"Vohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarah T.","family":"Colaizy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi L.","family":"Watterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R.","family":"Hintz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"1778_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett, M. E. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122, 200\u2013210 (2015).","journal-title":"Ophthalmology"},{"key":"1778_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaapos.2014.01.014","volume":"18","author":"EN Allred","year":"2014","unstructured":"Allred, E. N. et al. Retinopathy of prematurity and brain damage in the very preterm newborn. J. Aapos. 18, 241\u2013247 (2014).","journal-title":"J. Aapos."},{"key":"1778_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jamaophthalmol.2013.5812","volume":"132","author":"GE Holmstr\u00f6m","year":"2014","unstructured":"Holmstr\u00f6m, G. E. et al. Ophthalmologic outcome at 30 months\u2019 corrected age of a prospective Swedish cohort of children born before 27 weeks of gestation: the extremely preterm infants in Sweden study. JAMA Ophthalmol. 132, 182\u2013189 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"1778_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamaophthalmol.2016.0391","volume":"134","author":"KM Hellgren","year":"2016","unstructured":"Hellgren, K. M. et al. Ophthalmologic outcome of extremely preterm infants at 6.5 years of age: extremely preterm infants in Sweden Study (EXPRESS). JAMA Ophthalmol. 134, 555\u2013562 (2016).","journal-title":"JAMA Ophthalmol."},{"key":"1778_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jama.2013.282153","volume":"311","author":"B Schmidt","year":"2014","unstructured":"Schmidt, B., Davis, P. G., Asztalos, E. V., Solimano, A. & Roberts, R. S. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA 311, 523\u2013525 (2014).","journal-title":"JAMA"},{"key":"1778_CR6","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1136\/archdischild-2016-312533","volume":"102","author":"TJA Glass","year":"2017","unstructured":"Glass, T. J. A. et al. Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment. Arch. Dis. Child. Fetal Neonatal Ed. 102, F532\u2013F537 (2017).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"1778_CR7","doi-asserted-by":"publisher","first-page":"e20183537","DOI":"10.1542\/peds.2018-3537","volume":"144","author":"G Natarajan","year":"2019","unstructured":"Natarajan, G. et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 144, e20183537 (2019).","journal-title":"Pediatrics"},{"key":"1778_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1001\/jama.2018.14996","volume":"320","author":"DL Phelps","year":"2018","unstructured":"Phelps, D. L. et al. Effects of myo-inositol on type 1 retinopathy of prematurity among preterm infants <28 weeks\u2019 gestational age: a randomized clinical trial. JAMA 320, 1649\u20131658 (2018).","journal-title":"JAMA"},{"key":"1778_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0734282906297199","volume":"25","author":"CA Albers","year":"2007","unstructured":"Albers, C. A. & Grieve, A. J. Bayley Scales of Infant and Toddler Development, 3rd edition. J. Psychoeduc. Assess. 25, 180\u2013190 (2007).","journal-title":"J. Psychoeduc. Assess."},{"key":"1778_CR10","unstructured":"Achenbach, T. M., & Rescorla, L. A. Manual for the ASEBA School-age Forms & Profiles. (University of Vermont Research Center for Children, Youth, & Families, Burlington, VT, 2001)."},{"key":"1778_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","volume":"39","author":"R Palisano","year":"1997","unstructured":"Palisano, R. et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child Neurol. 39, 214\u2013223 (1997).","journal-title":"Dev. Med. Child Neurol."},{"key":"1778_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","volume":"87","author":"GR Alexander","year":"1996","unstructured":"Alexander, G. R., Himes, J. H., Kaufman, R. B., Mor, J. & Kogan, M. A United States national reference for fetal growth. Obstet. Gynecol. 87, 163\u2013168 (1996).","journal-title":"Obstet. Gynecol."},{"key":"1778_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529\u2013534 (1978).","journal-title":"J. Pediatr."},{"key":"1778_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/aos.13631","volume":"96","author":"K de Verdier","year":"2018","unstructured":"de Verdier, K., Ulla, E., L\u00f6fgren, S. & Fernell, E. Children with blindness \u2013 major causes, developmental outcomes and implications for habilitation and educational support: a two-decade, Swedish population-based study. Acta Ophthalmol. 96, 295\u2013300 (2018).","journal-title":"Acta Ophthalmol."},{"key":"1778_CR15","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1212\/01.wnl.0000437298.43688.b9","volume":"81","author":"V Chau","year":"2013","unstructured":"Chau, V. et al. Abnormal brain maturation in preterm neonates associated with adverse developmental outcomes. Neurology 81, 2082\u20132089 (2013).","journal-title":"Neurology"},{"key":"1778_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000487847","volume":"114","author":"K Sveinsd\u00f3ttir","year":"2018","unstructured":"Sveinsd\u00f3ttir, K. et al. Relation of retinopathy of prematurity to brain volumes at term equivalent age and developmental outcome at 2 years of corrected age in very preterm infants. Neonatology 114, 46\u201352 (2018).","journal-title":"Neonatology"},{"key":"1778_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/sj.jp.7211228","volume":"25","author":"V Sampath","year":"2005","unstructured":"Sampath, V., Bowen, J. & Gibson, F. Risk factors for adverse neurodevelopment in extremely low birth weight infants with normal neonatal cranial ultrasound. J. Perinatol. 25, 210\u2013215 (2005).","journal-title":"J. Perinatol."},{"key":"1778_CR18","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1542\/peds.106.5.998","volume":"106","author":"ME Msall","year":"2000","unstructured":"Msall, M. E. et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Pediatrics 106, 998\u20131005 (2000).","journal-title":"Pediatrics"},{"key":"1778_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jnp.12069","volume":"10","author":"CS Molloy","year":"2016","unstructured":"Molloy, C. S., Anderson, P. J., Anderson, V. A. & Doyle, L. W. The long-term outcome of extremely preterm (<28 weeks\u2019 gestational age) infants with and without severe retinopathy of prematurity. J. Neuropsychol. 10, 276\u2013294 (2016).","journal-title":"J. Neuropsychol."},{"key":"1778_CR20","doi-asserted-by":"publisher","first-page":"e20170257","DOI":"10.1542\/peds.2017-0257","volume":"140","author":"DS Costa","year":"2017","unstructured":"Costa, D. S. et al. Executive function and academic outcomes in children who were extremely preterm. Pediatrics 140, e20170257 (2017).","journal-title":"Pediatrics"},{"key":"1778_CR21","doi-asserted-by":"publisher","first-page":"e20154343","DOI":"10.1542\/peds.2015-4343","volume":"137","author":"RM Joseph","year":"2016","unstructured":"Joseph, R. M. et al. Neurocognitive and academic outcomes at age 10 years of extremely preterm newborns. Pediatrics 137, e20154343 (2016).","journal-title":"Pediatrics"},{"key":"1778_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/archopht.123.3.311","volume":"123","author":"EA Palmer","year":"2005","unstructured":"Palmer, E. A. et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch. Ophthalmol. 123, 311\u2013318 (2005).","journal-title":"Arch. Ophthalmol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01778-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:02:32Z","timestamp":1699016552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01778-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no potential or perceived conflicts of interest to disclose relevant to this manuscript. None of the authors report any commercial, proprietary, or financial interest in any of the products described in this article. NICHD is the sponsor of the study and holds the investigational new drug (IND) application. Abbott Nutrition Division, Abbott Laboratories, Columbus, OH, provided the <i>myo<\/i>-inositol product. They had no role in the design of the trial; the analyses, interpretation, or writing of the manuscript; or the decision to submit the manuscript for publication. They provided on-site monitoring to assist in quality assurance of the data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was a secondary analysis of the \u201cInositol to Reduce Retinopathy of Prematurity\u201d trial (NCT01954082); informed consent was required for participation in this trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}